Cargando…
Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN)
OBJECTIVE: Well-established cancer registries that routinely link to death registrations can estimate prevalence directly by counting patients alive at a particular point in time (observed prevalence). Such direct methods can only provide prevalence for the years over which the registry has been ope...
Autores principales: | Li, Jinlei, Smith, Alex, Crouch, Simon, Oliver, Steven, Roman, Eve |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958130/ https://www.ncbi.nlm.nih.gov/pubmed/27351920 http://dx.doi.org/10.1007/s10552-016-0780-z |
Ejemplares similares
-
Cohort Profile Update: The Haematological Malignancy Research Network (HMRN) UK population-based cohorts
por: Roman, Eve, et al.
Publicado: (2022) -
Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort
por: Smith, Alexandra, et al.
Publicado: (2018) -
The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research
por: Smith, Alexandra, et al.
Publicado: (2010) -
Impact of novel therapies for mantle cell lymphoma in the real world setting: a report from the UK's Haematological Malignancy Research Network (HMRN)
por: Smith, Alexandra, et al.
Publicado: (2018) -
Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK’s population-based Haematological Malignancy Research Network 2004–15
por: Roman, Eve, et al.
Publicado: (2016)